Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Clinical trial NCT00428948 · COMPLETED

Trial details

NCT number: NCT00428948
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Polycystic Kidney Disease, Autosomal Dominant

Start date: 2007-01-01
Primary completion: 2012-01-01
Enrollment: 1445

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.